|
US10048271B2
(en)
|
2012-12-11 |
2018-08-14 |
Albert Einstein College Of Medicine, Inc. |
Methods for high throughput receptor:ligand identification
|
|
RS61943B1
(sr)
|
2015-04-17 |
2021-07-30 |
Alpine Immune Sciences Inc |
Imunomodulatorni proteini sa prilagodljivim afinitetima
|
|
JP6936221B2
(ja)
|
2015-11-02 |
2021-09-15 |
ファイブ プライム セラピューティクス， インコーポレイテッド |
Ｃｄ８０細胞外ドメインポリペプチドと、がん治療でのそれらの使用
|
|
IL310729A
(en)
|
2016-04-15 |
2024-04-01 |
Alpine Immune Sciences Inc |
Immunomodulatory proteins that are variants of CD80 and their uses
|
|
US11505591B2
(en)
*
|
2016-05-18 |
2022-11-22 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
AU2017266905B2
(en)
|
2016-05-18 |
2022-12-15 |
Albert Einstein College Of Medicine, Inc. |
Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereof
|
|
EP3491013A1
(en)
|
2016-07-28 |
2019-06-05 |
Alpine Immune Sciences, Inc. |
Cd155 variant immunomodulatory proteins and uses thereof
|
|
KR102760578B1
(ko)
|
2016-12-22 |
2025-02-03 |
큐 바이오파마, 인크. |
T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법
|
|
US11851471B2
(en)
|
2017-01-09 |
2023-12-26 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
IL269000B2
(en)
|
2017-03-15 |
2024-06-01 |
Cue Biopharma Inc |
Methods for modulating an immune response
|
|
EP3596114A2
(en)
|
2017-03-16 |
2020-01-22 |
Alpine Immune Sciences, Inc. |
Cd80 variant immunomodulatory proteins and uses thereof
|
|
AU2018258661A1
(en)
|
2017-04-28 |
2019-10-17 |
Five Prime Therapeutics, Inc. |
Methods of treatment with CD80 extracellular domain polypeptides
|
|
TW201920249A
(zh)
*
|
2017-09-07 |
2019-06-01 |
美商信號生物製藥公司 |
具有結合位點之t細胞調節多聚體多肽及其使用方法
|
|
EP3678677A4
(en)
*
|
2017-09-07 |
2021-06-16 |
Cue Biopharma, Inc. |
Antigen-presenting polypeptides and methods of use thereof
|
|
CN111886241A
(zh)
|
2018-01-09 |
2020-11-03 |
库尔生物制药有限公司 |
多聚体t细胞调节多肽及其使用方法
|
|
WO2020132368A1
(en)
*
|
2018-12-19 |
2020-06-25 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereof
|
|
TW202045544A
(zh)
|
2019-02-22 |
2020-12-16 |
美商戊瑞治療有限公司 |
用於治療ＰＤ－Ｌ１陰性腫瘤之ＣＤ８０胞外結構域Ｆｃ融合蛋白
|
|
WO2020181272A1
(en)
*
|
2019-03-06 |
2020-09-10 |
Cue Biopharma, Inc. |
Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof
|
|
AU2020282736B2
(en)
*
|
2019-05-29 |
2025-10-30 |
Cue Biopharma, Inc. |
Multimeric T-cell modulatory polypeptides and methods of use thereof
|
|
WO2021055594A1
(en)
*
|
2019-09-20 |
2021-03-25 |
Cue Biopharma, Inc. |
T-cell modulatory polypeptides and methods of use thereof
|
|
MX2022004873A
(es)
|
2019-10-23 |
2022-05-13 |
Cue Biopharma Inc |
Polipeptidos de tgf-?.
|
|
WO2021178975A1
(en)
*
|
2020-03-06 |
2021-09-10 |
Albert Einstein College Of Medicine |
A method to generate chimeric antigen receptor (car) t-cells (car-t cells) from pathogen-specific cytotoxic lymphocytes to enable the subsequent in vivo modulation of their functional activity
|
|
JP2023517044A
(ja)
*
|
2020-03-09 |
2023-04-21 |
ファイザー・インク |
融合タンパク質およびその使用
|
|
WO2021231376A2
(en)
|
2020-05-12 |
2021-11-18 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
EP4157350A4
(en)
*
|
2020-05-26 |
2025-07-23 |
Cue Biopharma Inc |
ANTIGEN-PRESENTING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF
|
|
WO2021242935A1
(en)
*
|
2020-05-26 |
2021-12-02 |
Cue Biopharma, Inc. |
Antigen presenting polypeptide complexes and methods of use thereof
|
|
KR20230052881A
(ko)
*
|
2020-07-14 |
2023-04-20 |
큐 바이오파마, 인크. |
접합 부위를 갖는 t-세포 조절 폴리펩티드 및 이의 사용 방법
|
|
EP4211149A4
(en)
|
2020-09-09 |
2024-10-09 |
Cue Biopharma, Inc. |
MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
|
|
CA3216273A1
(en)
*
|
2021-04-21 |
2022-10-27 |
Ronald D. SEIDEL III |
Antigen presenting polypeptide complexes bearing tgf-beta and methods of use thereof
|
|
US20240270815A1
(en)
*
|
2021-05-26 |
2024-08-15 |
Cue Biopharma, Inc. |
Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
|